Gilead Sciences to Present at Two Upcoming Investor Conferences
September 08 2010 - 4:30PM
Business Wire
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the
company will be webcasting its corporate presentation at two
upcoming investor conferences: the Morgan Stanley Global Healthcare
Conference in New York and the Bank of America Merrill Lynch Global
Healthcare Conference in London.
John F. Milligan, PhD, Gilead’s President and Chief Operating
Officer, will provide an overview of the company at the Morgan
Stanley conference on Tuesday, September 14 at 1:35 p.m. Eastern
Daylight Time (EDT).
Kevin Young, Gilead’s Executive Vice President, Commercial
Operations, will provide an overview of the company at the Bank of
America Merrill Lynch conference on Wednesday, September 15 at 1:45
p.m. British Summer Time (8:45 a.m. EDT).
To access the live webcasts via the internet log on to
www.gilead.com. Please connect to the company’s website at least 15
minutes prior to each live presentation to ensure adequate time for
any software download that may be necessary to listen to the
webcast.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company's mission is to advance the care of
patients suffering from life-threatening diseases worldwide.
Headquartered in Foster City, California, Gilead has operations in
North America, Europe and Australia.
For more information on Gilead
Sciences, please visit www.gilead.com orcall the Gilead Public
Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024